{"pageContent": "Background: Focal therapy is an emerging mini-invasive treatment modality for localized prostate cancer aimed to reduce the morbidity associated with radical therapy while maintaining optimal cancer control. We report the mid-term oncological and functional results of primary hemiablation high-intensity focused ultrasound (HIFU) in a prospective cohort of patients.", "metaData": {"source": "Target ablation--image-guided therapy in prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/24411788/"}}